On this page
- Agilent Technologies Inc
- Alpha Pro Tech Ltd
- AMETEK Inc
- Applied Energetics, Inc.
- Avantor Inc
- Cognex Corp
- CONMED Corp
- Danaher Corp
- Dexcom Inc
- Edwards Lifesciences Corp
- Escalon Medical Corp.
- Hologic Inc
- Intuitive Surgical Inc
- Itron Inc
- KLA Corp
- Medtronic PLC
- Merit Medical Systems Inc
- Mirion Technologies Inc
- MSA Safety Inc
- Nexgel, Inc.
- Onto Innovation Inc
- Renovorx, Inc.
- Rockwell Automation Inc
- Sight Sciences, Inc.
- Solventum Corp
- Teledyne Technologies Inc
- Thermo Fisher Scientific Inc
- TransMedics Group Inc
Agilent Technologies Inc
Agilent Technologies Inc has 3 Schedule 13D or 13G filings on record since 2026-03-26. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 21,189,662 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Portfolio Management | 5.09% | 14,387,171 | SCHEDULE 13G, 2026-04-28 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 2,808,632 | 0 | 21,189,662 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Portfolio Management | 34,489 | 0 | 14,387,171 | 0 | SCHEDULE 13G, 2026-04-28 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Agilent Technologies Inc by CUSIP 00846U101 and gives its principal executive office as 5301 Stevens Creek Blvd, Santa Clara, CA 95051 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-28 | Vanguard Portfolio Management | 5.09% | SCHEDULE 13G |
| 2026-04-29 | Vanguard Capital Management | 7.49% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 8, 2026 | Leadership change: Boon Hwee Koh departs, Chairperson of the Board, and 1 more | — | Leadership changes | Source |
| May 27, 2026 | Leadership change: Tim Downs appointed, Chief Accounting Officer | — | Leadership changes | Source |
| May 4, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 6, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Alpha Pro Tech Ltd
Alpha Pro Tech Ltd has 4 Schedule 13D or 13G filings on record since 2026-02-13. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Needham Investment Management L.L.C. | 6.2% | 642,500 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Vanguard Capital Management | 4.29% | 438,457 | SCHEDULE 13G/A, 2026-10-30 | 2026-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Needham Investment Management L.L.C. | 0 | 642,500 | 0 | 642,500 | SCHEDULE 13G/A, 2026-02-13 |
| Needham Asset Management, LLC | 0 | 642,500 | 0 | 642,500 | SCHEDULE 13G/A, 2026-02-13 |
| Needham Aggressive Growth Fund | 0 | 642,500 | 0 | 642,500 | SCHEDULE 13G/A, 2026-02-13 |
| George A. Needham | 0 | 642,500 | 0 | 642,500 | SCHEDULE 13G/A, 2026-02-13 |
| Vanguard Capital Management | 55,749 | 0 | 438,457 | 0 | SCHEDULE 13G/A, 2026-10-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Alpha Pro Tech Ltd by CUSIP 020772109 and gives its principal executive office as 60 Centurian Drive, Suite 112, Markham (SCHEDULE 13G/A, 2026-10-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-02-13 | Needham Investment Management L.L.C. | 6.2% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-28 | Vanguard Capital Management | 5.97% | SCHEDULE 13G |
| 2026-10-30 | Vanguard Capital Management | 4.29% | SCHEDULE 13G/A |
AMETEK Inc
AMETEK Inc has 2 Schedule 13D or 13G filings on record since 2026-03-26. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 17,175,368 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 2,248,853 | 0 | 17,175,368 | 0 | SCHEDULE 13G, 2026-04-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies AMETEK Inc by CUSIP 031100100 and gives its principal executive office as 1100 Cassatt Rd, Berwyn, PA 19312 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 7.49% | SCHEDULE 13G |
Applied Energetics, Inc.
Applied Energetics, Inc. has 1 Schedule 13D or 13G filing on record since 2026-04-23. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Ingalls & Snyder LLC | 7.7% | 17,230,596 | SCHEDULE 13G, 2026-04-23 | 2025-12-31 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Ingalls & Snyder LLC | 0 | 0 | 0 | 17,230,596 | SCHEDULE 13G, 2026-04-23 |
The latest filing identifies Applied Energetics, Inc. by CUSIP 03819M106 and gives its principal executive office as 9070 S. RITA ROAD, SUITE 1500, TUCSON, AZ 85747 (SCHEDULE 13G, 2026-04-23).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-04-23 | Ingalls & Snyder LLC | 7.7% | SCHEDULE 13G |
Avantor Inc
Avantor Inc has 6 Schedule 13D or 13G filings on record since 2025-08-13. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Dodge & Cox | 17.2% | 117,433,484 | SCHEDULE 13G/A, 2025-08-13 | 2025-06-30 |
| BlackRock, Inc. | 8.7% | 59,049,575 | SCHEDULE 13G/A, 2025-10-17 | 2025-09-30 |
| Vanguard Capital Management | 5.29% | 35,802,263 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 4.8% | 32,928,415 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 56,188,076 | 0 | 59,049,575 | 0 | SCHEDULE 13G/A, 2025-10-17 |
| Vanguard Capital Management | 5,196,151 | 0 | 35,802,263 | 0 | SCHEDULE 13G, 2026-04-29 |
| T. Rowe Price Investment Management, Inc. | 32,838,902 | 0 | 32,928,415 | 0 | SCHEDULE 13G/A, 2025-11-14 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Avantor Inc by CUSIP 05352A100 and gives its principal executive office as Radnor Corporate Center Bldg 1, Ste 200, Radnor, PA 19087 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-13 | Dodge & Cox | 17.2% | SCHEDULE 13G/A |
| 2025-08-14 | T. Rowe Price Investment Management, Inc. | 8.3% | SCHEDULE 13G/A |
| 2025-10-17 | BlackRock, Inc. | 8.7% | SCHEDULE 13G/A |
| 2025-11-14 | T. Rowe Price Investment Management, Inc. | 4.8% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 5.29% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 21, 2026 | Leadership change: Todd Garner appointed | — | Leadership changes | Source |
| September 21, 2026 | Leadership change: Todd Garner appointed | — | Leadership changes | Source |
| August 27, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 23, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 1, 2026 | Leadership change: R. Brent Jones departs, Chief Financial Officer | — | Leadership changes | Source |
Cognex Corp
Cognex Corp has 4 Schedule 13D or 13G filings on record since 2025-10-30. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Portfolio Management | 6.22% | 10,390,950 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Capital Management | 5.21% | 8,705,689 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Portfolio Management | 20,303 | 0 | 10,390,950 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Capital Management | 1,275,533 | 0 | 8,705,689 | 0 | SCHEDULE 13G, 2026-04-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Cognex Corp by CUSIP 192422103 and gives its principal executive office as 1 Vision Drive, Natick, MA 01760 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-30 | The Vanguard Group | 11.07% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 5.21% | SCHEDULE 13G |
| 2026-04-29 | Vanguard Portfolio Management | 6.22% | SCHEDULE 13G |
CONMED Corp
CONMED Corp has 6 Schedule 13D or 13G filings on record since 2025-07-18. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 15.1% | 4,679,441 | SCHEDULE 13G/A, 2025-07-18 | 2025-06-30 |
| Vanguard Portfolio Management | 6.87% | 2,120,886 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Fuller & Thaler Asset Management, Inc. | 5.63% | 1,740,630 | SCHEDULE 13G, 2025-08-14 | 2025-06-30 |
| Vanguard Capital Management | 5.25% | 1,619,070 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Capital Research Global Investors | 3.3% | 1,032,733 | SCHEDULE 13G/A, 2025-11-13 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Portfolio Management | 44,469 | 0 | 2,120,886 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Capital Management | 235,028 | 0 | 1,619,070 | 0 | SCHEDULE 13G, 2026-04-29 |
| Capital Research Global Investors | 1,032,733 | 0 | 1,032,733 | 0 | SCHEDULE 13G/A, 2025-11-13 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies CONMED Corp by CUSIP 207410101 and gives its principal executive office as 525 French Road, New York, NY 13502 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-18 | BlackRock, Inc. | 15.1% | SCHEDULE 13G/A |
| 2025-08-14 | Fuller & Thaler Asset Management, Inc. | 5.63% | SCHEDULE 13G |
| 2025-11-13 | Capital Research Global Investors | 3.3% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 5.25% | SCHEDULE 13G |
| 2026-04-29 | Vanguard Portfolio Management | 6.87% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| June 17, 2026 | Leadership change: John E. Gallagher appointed, Chief Financial Officer | — | Leadership changes | Source |
| May 20, 2026 | Leadership change: Celine Martin appointed, Director, and 2 more | — | Leadership changes | Source |
Danaher Corp
Danaher Corp has 3 Schedule 13D or 13G filings on record since 2026-01-30. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 6.69% | 47,383,707 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 6,255,897 | 0 | 47,383,707 | 0 | SCHEDULE 13G, 2026-04-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Danaher Corp by CUSIP 235851102 and gives its principal executive office as 2200 Pennsylvania Avenue, Northwest, Washington, DC 20037 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-30 | The Vanguard Group | 8.63% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 6.69% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 13, 2026 | Leadership change: Daniel L. Comas appointed, and 1 more | — | Leadership changes | Source |
| August 3, 2026 | Leadership change: Rainer M. Blair appointed | — | Leadership changes | Source |
Dexcom Inc
Dexcom Inc has 4 Schedule 13D or 13G filings on record since 2025-10-30. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 28,848,218 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Portfolio Management | 5.02% | 19,322,566 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 3,827,257 | 0 | 28,848,218 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Portfolio Management | 102,613 | 0 | 19,322,566 | 0 | SCHEDULE 13G, 2026-04-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Dexcom Inc by CUSIP 252131107 and gives its principal executive office as 6340 Sequence Drive, San Diego, CA 92121 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-30 | The Vanguard Group | 12.61% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 7.49% | SCHEDULE 13G |
| 2026-04-29 | Vanguard Portfolio Management | 5.02% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 14, 2026 | Leadership change: Jereme Sylvain appointed, Chief Financial Officer | — | Leadership changes | Source |
| September 10, 2026 | Leadership change: Glenn S. Boehnlein appointed, Director, and 1 more | — | Leadership changes | Source |
Edwards Lifesciences Corp
Edwards Lifesciences Corp has 4 Schedule 13D or 13G filings on record since 2025-08-12. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.54% | 43,477,533 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| BlackRock, Inc. | 7.5% | 44,267,376 | SCHEDULE 13G/A, 2025-10-17 | 2025-09-30 |
| Wellington Management Group LLP | 3.4% | 19,826,483 | SCHEDULE 13G/A, 2025-08-12 | 2025-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 5,749,741 | 0 | 43,477,533 | 0 | SCHEDULE 13G, 2026-04-29 |
| BlackRock, Inc. | 40,035,206 | 0 | 44,267,376 | 0 | SCHEDULE 13G/A, 2025-10-17 |
| Wellington Management Group LLP | 0 | 18,601,111 | 0 | 19,826,483 | SCHEDULE 13G/A, 2025-08-12 |
| Wellington Group Holdings LLP | 0 | 18,601,111 | 0 | 19,826,483 | SCHEDULE 13G/A, 2025-08-12 |
| Wellington Investment Advisors Holdings LLP | 0 | 18,601,111 | 0 | 19,826,483 | SCHEDULE 13G/A, 2025-08-12 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Edwards Lifesciences Corp by CUSIP 28176E108 and gives its principal executive office as 1 Edwards Way, Irvine, CA 92614 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-12 | Wellington Management Group LLP | 3.4% | SCHEDULE 13G/A |
| 2025-10-17 | BlackRock, Inc. | 7.5% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 7.54% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 28, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| May 4, 2026 | Leadership change: Theodora Mistras appointed, Chief Financial Officer | — | Leadership changes | Source |
Escalon Medical Corp.
Escalon Medical Corp. has 3 Schedule 13D or 13G filings on record since 2025-07-08. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| LPL Financial LLC | 7.9% | 586,749 | SCHEDULE 13G, 2026-04-09 | 2026-03-31 |
| Newton Charles Carter | 0% | 0 | SCHEDULE 13G/A, 2025-10-06 | 2025-10-06 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| LPL Financial LLC | 0 | 0 | 0 | 586,749 | SCHEDULE 13G, 2026-04-09 |
| Newton Charles Carter | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-10-06 |
The latest filing identifies Escalon Medical Corp. by CUSIP 296074305 and gives its principal executive office as 435 Devon Park Drive, Suite 824, Wayne, PA 19087 (SCHEDULE 13G, 2026-04-09).
The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G. Percentage ownership is based on 7,415,329 shares of Common Stock outstanding as of February 13, 2026, as reported in the Issuer's Report on Form 10-Q for the period ended December 31, 2025 filed with the Securities and Exchange Commission on February 17, 2026.LPL Financial LLC, SCHEDULE 13G, 2026-04-09
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-08 | Newton Charles Carter | 6.3% | SCHEDULE 13G/A |
| 2025-10-06 | Newton Charles Carter | 0% | SCHEDULE 13G/A |
| 2026-04-09 | LPL Financial LLC | 7.9% | SCHEDULE 13G |
Hologic Inc
Hologic Inc has 5 Schedule 13D or 13G filings on record since 2025-07-08. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 16,721,923 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 2.7% | 5,932,301 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 2,218,009 | 0 | 16,721,923 | 0 | SCHEDULE 13G, 2026-04-30 |
| T. Rowe Price Investment Management, Inc. | 5,914,773 | 0 | 5,932,301 | 0 | SCHEDULE 13G/A, 2026-02-17 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Hologic Inc by CUSIP 436440101 and gives its principal executive office as 250 Campus Drive, Marlborough, MA 01752 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-08 | T. Rowe Price Investment Management, Inc. | 10.8% | SCHEDULE 13G/A |
| 2025-11-14 | T. Rowe Price Investment Management, Inc. | 9.7% | SCHEDULE 13G/A |
| 2026-02-17 | T. Rowe Price Investment Management, Inc. | 2.7% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 7.49% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 7, 2026 | Acquired by Hopper Parent Inc. | — | Acquisition | Source |
| April 7, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 6, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Intuitive Surgical Inc
Intuitive Surgical Inc has 2 Schedule 13D or 13G filings on record since 2026-03-27. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 26,601,419 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 3,521,929 | 0 | 26,601,419 | 0 | SCHEDULE 13G, 2026-04-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Intuitive Surgical Inc by CUSIP 46120E602 and gives its principal executive office as 1020 Kifer Rd, Sunnyvale, CA 94086 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 7.49% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 2, 2026 | Leadership change: Aaron Martin appointed | — | Leadership changes | Source |
| May 28, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Itron Inc
Itron Inc has 4 Schedule 13D or 13G filings on record since 2025-11-06. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Portfolio Management | 7.97% | 3,534,821 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Capital Management | 5.33% | 2,362,484 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Invesco Ltd. | 4.9% | 2,263,698 | SCHEDULE 13G/A, 2025-11-06 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Portfolio Management | 28,154 | 0 | 3,534,821 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Capital Management | 348,364 | 0 | 2,362,484 | 0 | SCHEDULE 13G, 2026-04-30 |
| Invesco Ltd. | 2,170,013 | 0 | 2,263,698 | 0 | SCHEDULE 13G/A, 2025-11-06 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Itron Inc by CUSIP 465741106 and gives its principal executive office as 2111 North Molter Road, Liberty Lake, WA 99019 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-11-06 | Invesco Ltd. | 4.9% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Portfolio Management | 7.97% | SCHEDULE 13G |
| 2026-04-30 | Vanguard Capital Management | 5.33% | SCHEDULE 13G |
KLA Corp
KLA Corp has 2 Schedule 13D or 13G filings on record since 2026-03-27. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 9,822,421 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 1,303,047 | 0 | 9,822,421 | 0 | SCHEDULE 13G, 2026-04-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies KLA Corp by CUSIP 482480100 and gives its principal executive office as One Technology Drive, Milpitas, CA 95035 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 7.49% | SCHEDULE 13G |
Medtronic PLC
Medtronic PLC has 3 Schedule 13D or 13G filings on record since 2025-12-03. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.51% | 96,424,044 | SCHEDULE 13G, 2026-04-28 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 13,090,211 | 0 | 96,424,044 | 0 | SCHEDULE 13G, 2026-04-28 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Medtronic PLC by CUSIP G5960L103 and gives its principal executive office as BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY (SCHEDULE 13G, 2026-04-28).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-12-03 | The Vanguard Group | 10.21% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-28 | Vanguard Capital Management | 7.51% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 19, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| May 18, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Merit Medical Systems Inc
Merit Medical Systems Inc has 4 Schedule 13D or 13G filings on record since 2025-10-17. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 14.1% | 8,370,301 | SCHEDULE 13G/A, 2025-10-17 | 2025-09-30 |
| Vanguard Portfolio Management | 6.01% | 3,571,916 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Capital Management | 5.23% | 3,109,720 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8,266,306 | 0 | 8,370,301 | 0 | SCHEDULE 13G/A, 2025-10-17 |
| Vanguard Portfolio Management | 48,828 | 0 | 3,571,916 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Capital Management | 453,557 | 0 | 3,109,720 | 0 | SCHEDULE 13G, 2026-04-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Merit Medical Systems Inc by CUSIP 589889104 and gives its principal executive office as 1600 West Merit Parkway, South Jordan, UT 84095 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-17 | BlackRock, Inc. | 14.1% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Portfolio Management | 6.01% | SCHEDULE 13G |
| 2026-04-30 | Vanguard Capital Management | 5.23% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 20, 2026 | Leadership change: Sheri Lewis appointed, Executive Vice President | — | Leadership changes | Source |
Mirion Technologies Inc
Mirion Technologies Inc has 7 Schedule 13D or 13G filings on record since 2025-10-02. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 14.8% | 35,690,382 | SCHEDULE 13G/A, 2025-10-02 | 2025-09-30 |
| Vanguard Portfolio Management | 7.4% | 18,118,998 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 6.1% | 15,112,855 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| Vanguard Capital Management | 5.03% | 12,327,150 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Kuwait Investment Authority, acting for and on behalf of the Government of the State of Kuwait (KIA) | 4.1% | 10,171,591 | SCHEDULE 13G/A, 2026-01-21 | 2022-07-29 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Portfolio Management | 213,276 | 0 | 18,118,998 | 0 | SCHEDULE 13G, 2026-04-29 |
| T. Rowe Price Investment Management, Inc. | 15,076,254 | 0 | 15,112,855 | 0 | SCHEDULE 13G/A, 2026-02-17 |
| Vanguard Capital Management | 1,821,955 | 0 | 12,327,150 | 0 | SCHEDULE 13G, 2026-04-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Mirion Technologies Inc by CUSIP 60471A101 and gives its principal executive office as 1218 Menlo Drive, Atlanta, GA 30318 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-02 | BlackRock, Inc. | 14.8% | SCHEDULE 13G/A |
| 2025-10-31 | The Vanguard Group | 12.45% | SCHEDULE 13G/A |
| 2026-01-21 | Kuwait Investment Authority, acting for and on behalf of the Government of the State of Kuwait (KIA) | 4.1% | SCHEDULE 13G/A |
| 2026-02-17 | T. Rowe Price Investment Management, Inc. | 6.1% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Portfolio Management | 7.4% | SCHEDULE 13G |
| 2026-04-30 | Vanguard Capital Management | 5.03% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 2, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
MSA Safety Inc
MSA Safety Inc has 3 Schedule 13D or 13G filings on record since 2025-07-31. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 5.12% | 1,985,590 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Jpmorgan Chase & Co. | 4.6% | 1,808,296 | SCHEDULE 13G/A, 2025-07-31 | 2025-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 281,807 | 0 | 1,985,590 | 0 | SCHEDULE 13G, 2026-04-30 |
| Jpmorgan Chase & Co. | 1,665,714 | 1 | 1,807,219 | 815 | SCHEDULE 13G/A, 2025-07-31 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies MSA Safety Inc by CUSIP 553498106 and gives its principal executive office as 1000 Cranberry Woods Drive, Cranberry Township, PA 16066 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-31 | Jpmorgan Chase & Co. | 4.6% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 5.12% | SCHEDULE 13G |
Nexgel, Inc.
Nexgel, Inc. has 2 Schedule 13D or 13G filings on record since 2026-03-12. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Asymmetry Point LP | 8.8% | 745,000 | SCHEDULE 13G/A, 2026-04-29 | 2026-03-31 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Asymmetry Point LP | 745,000 | 0 | 745,000 | 0 | SCHEDULE 13G/A, 2026-04-29 |
| Asymmetry Point Capital LLC | 745,000 | 0 | 745,000 | 0 | SCHEDULE 13G/A, 2026-04-29 |
| Mr. Aviv Argaman | 745,000 | 0 | 745,000 | 0 | SCHEDULE 13G/A, 2026-04-29 |
The latest filing identifies Nexgel, Inc. by CUSIP 65344E107 and gives its principal executive office as 2150 CABOT BLVD WEST, Suite B, LANGHORNE, PA 19047 (SCHEDULE 13G/A, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-12 | Asymmetry Point LP | 7.49% | SCHEDULE 13G |
| 2026-04-29 | Asymmetry Point LP | 8.8% | SCHEDULE 13G/A |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 21, 2026 | Leadership change: Brian Kieser appointed, Chief Executive Officer | — | Leadership changes | Source |
| July 2, 2026 | Leadership change: Scott Henry departs | — | Leadership changes | Source |
| May 12, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 30, 2026 | Leadership change: Ian Blackman appointed, Chief Financial Officer | — | Leadership changes | Source |
Onto Innovation Inc
Onto Innovation Inc has 4 Schedule 13D or 13G filings on record since 2025-10-17. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 10.3% | 5,039,082 | SCHEDULE 13G/A, 2025-10-17 | 2025-09-30 |
| Vanguard Portfolio Management | 5.53% | 2,751,547 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Capital Management | 5.23% | 2,602,830 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,872,451 | 0 | 5,039,082 | 0 | SCHEDULE 13G/A, 2025-10-17 |
| Vanguard Portfolio Management | 8,528 | 0 | 2,751,547 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Capital Management | 379,978 | 0 | 2,602,830 | 0 | SCHEDULE 13G, 2026-04-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Onto Innovation Inc by CUSIP 683344105 and gives its principal executive office as 16 Jonspin Road, Wilmington, MA 01887 (SCHEDULE 13G, 2026-04-29).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-17 | BlackRock, Inc. | 10.3% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 5.23% | SCHEDULE 13G |
| 2026-04-29 | Vanguard Portfolio Management | 5.53% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 17, 2025 | Acquired Semilab USA LLC | $432.31M | Acquisition | Source |
Renovorx, Inc.
Renovorx, Inc. has 5 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Orin Hirschman | 9.8% | 4,430,439 | SCHEDULE 13G/A, 2026-04-27 | 2026-03-31 |
| AWM Investment Company, Inc. | 2.4% | 863,790 | SCHEDULE 13G/A, 2025-11-13 | 2025-09-30 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Orin Hirschman | 4,430,439 | 0 | 4,430,439 | 0 | SCHEDULE 13G/A, 2026-04-27 |
| AIGH Capital Management LLC | 4,430,493 | 0 | 4,430,493 | 0 | SCHEDULE 13G/A, 2026-04-27 |
| AWM Investment Company, Inc. | 863,790 | 0 | 863,790 | 0 | SCHEDULE 13G/A, 2025-11-13 |
The latest filing identifies Renovorx, Inc. by CUSIP 75989R107 and gives its principal executive office as 2570 West El Camino Real, Suite 320, Mountain View, CA 94040 (SCHEDULE 13G/A, 2026-04-27).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | AWM Investment Company, Inc. | 5.1% | SCHEDULE 13G/A |
| 2025-11-10 | Orin Hirschman | 7.1% | SCHEDULE 13G/A |
| 2025-11-13 | AWM Investment Company, Inc. | 2.4% | SCHEDULE 13G/A |
| 2026-01-30 | Orin Hirschman | 7.1% | SCHEDULE 13G/A |
| 2026-04-27 | Orin Hirschman | 9.8% | SCHEDULE 13G/A |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 9, 2026 | Form D, private offering | $10M sold | Form D page | Source |
Rockwell Automation Inc
Rockwell Automation Inc has 5 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 9.1% | 10,222,503 | SCHEDULE 13G/A, 2026-04-24 | 2026-03-31 |
| Vanguard Capital Management | 7.47% | 8,400,924 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Vanguard Portfolio Management | 5.21% | 5,860,884 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| T. Rowe Price Associates, Inc. | 4.4% | 4,997,025 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,494,309 | 0 | 10,222,503 | 0 | SCHEDULE 13G/A, 2026-04-24 |
| Vanguard Capital Management | 1,099,093 | 0 | 8,400,924 | 0 | SCHEDULE 13G, 2026-04-30 |
| Vanguard Portfolio Management | 15,150 | 0 | 5,860,884 | 0 | SCHEDULE 13G, 2026-04-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Rockwell Automation Inc by CUSIP 773903109 and gives its principal executive office as 1201 South Second Street, Milwaukee, WI 53204 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | T. Rowe Price Associates, Inc. | 4.4% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-24 | BlackRock, Inc. | 9.1% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Portfolio Management | 5.21% | SCHEDULE 13G |
| 2026-04-30 | Vanguard Capital Management | 7.47% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 24, 2026 | Leadership change: Scott A. Genereux departs | — | Leadership changes | Source |
| April 17, 2026 | Leadership change: David A. Zapico appointed, Director | — | Leadership changes | Source |
Sight Sciences, Inc.
Sight Sciences, Inc. has 3 Schedule 13D or 13G filings on record since 2026-01-21. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 5.01% | 2,651,156 | SCHEDULE 13G, 2026-01-21 | 2025-12-31 |
| Kck Ltd. | 2.7% | 1,438,094 | SCHEDULE 13G/A, 2026-04-08 | 2026-03-31 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,614,209 | 0 | 2,651,156 | 0 | SCHEDULE 13G, 2026-01-21 |
| Kck Ltd. | 0 | 1,438,094 | 0 | 1,438,094 | SCHEDULE 13G/A, 2026-04-08 |
| Nael Karim Kassar | 0 | 1,438,094 | 0 | 1,438,094 | SCHEDULE 13G/A, 2026-04-08 |
The latest filing identifies Sight Sciences, Inc. by CUSIP 82657M105 and gives its principal executive office as 4040 CAMPBELL AVE, SUITE 100, MENLO PARK, CA 94025 (SCHEDULE 13G/A, 2026-04-08).
The ownership percentage reported is based on 54,005,984 shares of Common Stock outstanding as of February 26, 2026, as reported in the Issuer's Annual Report on Form 10-K filed with the SEC on March 4, 2026.Kck Ltd., SCHEDULE 13G/A, 2026-04-08
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-21 | BlackRock, Inc. | 5.01% | SCHEDULE 13G |
| 2026-02-04 | Kck Ltd. | 7% | SCHEDULE 13G/A |
| 2026-04-08 | Kck Ltd. | 2.7% | SCHEDULE 13G/A |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 10, 2026 | Leadership change: Kashif Rashid appointed, Chief Legal Officer | — | Leadership changes | Source |
Solventum Corp
Solventum Corp has 6 Schedule 13D or 13G filings on record since 2025-08-13. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 3M Company | 14.8% | 25,569,190 | SCHEDULE 13G/A, 2025-08-18 | 2025-08-15 |
| Independent Franchise Partners, LLP | 8.85% | 15,355,691 | SCHEDULE 13G/A, 2026-01-27 | 2025-12-31 |
| Vanguard Capital Management | 6.27% | 10,875,310 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Independent Franchise Partners, LLP | 15,002,913 | 91,652 | 15,355,691 | 0 | SCHEDULE 13G/A, 2026-01-27 |
| Vanguard Capital Management | 1,273,361 | 0 | 10,875,310 | 0 | SCHEDULE 13G, 2026-04-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Solventum Corp by CUSIP 83444M101 and gives its principal executive office as 3M Center, Building 275-6W, St Paul, MN 55144 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-13 | Independent Franchise Partners, LLP | 5.86% | SCHEDULE 13G |
| 2025-08-18 | 3M Company | 14.8% | SCHEDULE 13G/A |
| 2025-11-13 | Independent Franchise Partners, LLP | 7.44% | SCHEDULE 13G/A |
| 2026-01-27 | Independent Franchise Partners, LLP | 8.85% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 6.27% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 20, 2026 | Leadership change: Neil Zieselman appointed, Chief Accounting Officer | — | Leadership changes | Source |
Teledyne Technologies Inc
Teledyne Technologies Inc has 5 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.53% | 3,489,014 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| T. Rowe Price Associates, Inc. | 6.7% | 3,126,015 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| Vanguard Portfolio Management | 5.14% | 2,384,961 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 458,232 | 0 | 3,489,014 | 0 | SCHEDULE 13G, 2026-04-30 |
| Vanguard Portfolio Management | 5,633 | 0 | 2,384,961 | 0 | SCHEDULE 13G, 2026-04-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Teledyne Technologies Inc by CUSIP 879360105 and gives its principal executive office as 1049 Camino Dos Rios, Thousand Oaks, CA 91360 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | T. Rowe Price Associates, Inc. | 6.7% | SCHEDULE 13G/A |
| 2026-01-30 | The Vanguard Group | 12.73% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Portfolio Management | 5.14% | SCHEDULE 13G |
| 2026-04-30 | Vanguard Capital Management | 7.53% | SCHEDULE 13G |
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc has 2 Schedule 13D or 13G filings on record since 2026-03-27. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Capital Management | 7.53% | 28,008,822 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 3,728,006 | 0 | 28,008,822 | 0 | SCHEDULE 13G, 2026-04-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Thermo Fisher Scientific Inc by CUSIP 883556102 and gives its principal executive office as 168 3RD AVE, WALTHAM, MA 02451 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 7.53% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 30, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
TransMedics Group Inc
TransMedics Group Inc has 4 Schedule 13D or 13G filings on record since 2025-07-18. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 14.6% | 4,955,262 | SCHEDULE 13G/A, 2025-07-18 | 2025-06-30 |
| Vanguard Portfolio Management | 5.68% | 1,949,420 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Vanguard Capital Management | 5.06% | 1,737,137 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,897,189 | 0 | 4,955,262 | 0 | SCHEDULE 13G/A, 2025-07-18 |
| Vanguard Portfolio Management | 29,885 | 0 | 1,949,420 | 0 | SCHEDULE 13G, 2026-04-29 |
| Vanguard Capital Management | 258,985 | 0 | 1,737,137 | 0 | SCHEDULE 13G, 2026-04-30 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies TransMedics Group Inc by CUSIP 89377M109 and gives its principal executive office as 200 Minuteman Road, Suite 302, Andover, MA 01810 (SCHEDULE 13G, 2026-04-30).
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-18 | BlackRock, Inc. | 14.6% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Portfolio Management | 5.68% | SCHEDULE 13G |
| 2026-04-30 | Vanguard Capital Management | 5.06% | SCHEDULE 13G |
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 10, 2026 | Leadership change: Fernando Araujo appointed, Chief Financial Officer, and 1 more | — | Leadership changes | Source |
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.
